The numbers tell a compelling story. When Harel Insurance Investments reports a quarterly comprehensive income after tax of NIS 1.024 billion, a 30% leap from a year ago, it’s not just a headline. It’s a signal. That figure, anchored by a staggering 37% return on equity, suggests a financial engine hitting its stride. But here in the Financial District, we know the raw data is only the start. The real narrative lies in the why and the how—in the quiet shifts of capital and risk that underpin these results.
My own conversations with analysts covering the sector often circle back to a core tension: growth versus stability. Harel’s report for the first half of 2026, showing total premiums and contributions surging 18% to NIS 25.5 billion, speaks directly to that. This isn’t passive accumulation. It’s active, deliberate scaling. The firm’s assets under management now stand at NIS 638 billion, a 10% climb since the end of 2025 alone. That scale provides a formidable moat but as I’ve learned watching other financial giants, it also brings immense complexity. The decision by Harel’s board to shift to a quarterly dividend policy, accompanied by a NIS 400 million payout, is a confident gesture. It signals a belief in sustained, predictable cash generation, a message aimed directly at shareholders seeking reliable income. Since January, they’ve returned roughly NIS 1.5 billion between dividends and buybacks. That’s capital discipline in action.
Yet the most analytically rich part of their disclosure is often the most opaque to the general reader: the Contractual Service Margin, or CSM. Think of it not as cash in the bank today but as the present value of all the future profits expected from current insurance contracts. It’s the franchise value quantified. Harel’s total CSM grew to NIS 17.7 billion, a massive reservoir of future earnings. More critically, the CSM from new sales in the first half hit NIS 992 million, 23% higher than last year. Here’s the kicker: that new business value exceeded the NIS 830 million of CSM released to current-period profit. In plain English, they are adding fuel to the tank faster than they’re burning it. This is a powerful indicator of health, driven by what the company calls a “focus on risk products” like critical illness coverage. It suggests the growth is high-quality, built on products that should deliver durable margins.
Drilling down, the performance wasn’t uniform across the board, which is typical for a diversified financial group. The insurance segment’s core profits were a story of two halves. While life and health saw some pressure earlier in the year from higher claims, the non-life business improved. But the standout engines were elsewhere. Core profits from asset management and credit soared 68% collectively in the second quarter. Management fees, propelled by that swelling AUM, fed a 58% jump in asset management profits. The credit segment, with its portfolio ballooning by NIS 2.3 billion in a year to NIS 8.8 billion, saw profits rise 32%. This tells us where Harel’s aggressive growth is currently concentrated: not just in underwriting risk but in managing and financing assets.
The breakdown by division reveals the nuances. Health insurance showed strong comprehensive income growth, though underwriting profit—the pure result of pricing risk correctly—was down year-over-year. Life insurance followed a similar pattern. The non-life segment, however, managed to increase its underwriting profit slightly. This mixed picture in underwriting underscores a reality in insurance: underwriting cycles and claims experience can create volatility, even in a growing top-line business. The steadier, fee-based streams from asset management and credit provide a valuable counterbalance.
- Quarterly comprehensive income after tax of NIS 1.024 billion
- 37% return on equity
- Total premiums and contributions surged 18% to NIS 25.5 billion
- Assets under management now stand at NIS 638 billion
- CSM grew to NIS 17.7 billion
- Quarterly dividend policy with NIS 400 million payout
| Segment | Core Profits | Growth Rate |
|---|---|---|
| Asset Management | NIS X billion | 58% |
| Credit | NIS 8.8 billion | 32% |
| Health Insurance | NIS Y billion | Strong |
| Life Insurance | NIS Z billion | Decline |
| Non-Life | NIS W billion | Slight Increase |
So, what’s the takeaway for an observer of financial institutions? Harel’s first-half 2026 results paint a portrait of a company successfully executing a dual strategy. It is deepening its core insurance franchise, as evidenced by the robust CSM growth from new, higher-margin products. Simultaneously, it is aggressively leveraging its balance sheet and market position to expand in asset-sensitive businesses like credit and funds management. The shift to quarterly dividends formalizes the return of this success to shareholders. The challenge, as always, will be maintaining underwriting discipline amid rapid expansion and managing the risks inherent in a fast-growing credit book. For now, the numbers from Tel Aviv tell a story of momentum, one that the market will likely view with a mix of admiration and heightened expectation.
